Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

348 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Biologic therapy in idiopathic inflammatory myopathy].
Selva-O'Callaghan A, Ramos Casals M, Grau Junyent JM. Selva-O'Callaghan A, et al. Among authors: ramos casals m. Med Clin (Barc). 2014 Sep 15;143(6):275-80. doi: 10.1016/j.medcli.2013.11.009. Epub 2014 Jan 3. Med Clin (Barc). 2014. PMID: 24393419 Review. Spanish.
Off-label use of rituximab in 196 patients with severe, refractory systemic autoimmune diseases.
Ramos-Casals M, García-Hernández FJ, de Ramón E, Callejas JL, Martínez-Berriotxoa A, Pallarés L, Caminal-Montero L, Selva-O'Callaghan A, Oristrell J, Hidalgo C, Pérez-Alvarez R, Micó ML, Medrano F, Gómez de la Torre R, Díaz-Lagares C, Camps M, Ortego N, Sánchez-Román J; BIOGEAS Study Group. Ramos-Casals M, et al. Clin Exp Rheumatol. 2010 Jul-Aug;28(4):468-76. Epub 2010 Aug 30. Clin Exp Rheumatol. 2010. PMID: 20525449
Efficacy of rituximab in 164 patients with biopsy-proven lupus nephritis: pooled data from European cohorts.
Díaz-Lagares C, Croca S, Sangle S, Vital EM, Catapano F, Martínez-Berriotxoa A, García-Hernández F, Callejas-Rubio JL, Rascón J, D'Cruz D, Jayne D, Ruiz-Irastorza G, Emery P, Isenberg D, Ramos-Casals M, Khamashta MA; UK-BIOGEAS Registry. Díaz-Lagares C, et al. Among authors: ramos casals m. Autoimmun Rev. 2012 Mar;11(5):357-64. doi: 10.1016/j.autrev.2011.10.009. Epub 2011 Oct 18. Autoimmun Rev. 2012. PMID: 22032879
Rates of, and risk factors for, severe infections in patients with systemic autoimmune diseases receiving biological agents off-label.
Díaz-Lagares C, Pérez-Alvarez R, García-Hernández FJ, Ayala-Gutiérrez MM, Callejas JL, Martínez-Berriotxoa A, Rascón J, Caminal-Montero L, Selva-O'Callaghan A, Oristrell J, Hidalgo C, Gómez-de-la-Torre R, Sáez L, Canora-Lebrato J, Camps MT, Ortego-Centeno N, Castillo-Palma MJ, Ramos-Casals M; BIOGEAS Study Group. Díaz-Lagares C, et al. Among authors: ramos casals m. Arthritis Res Ther. 2011 Jul 11;13(4):R112. doi: 10.1186/ar3397. Arthritis Res Ther. 2011. PMID: 21745378 Free PMC article.
[Recommendations on the use of belimumab in systemic lupus erythematosus. GEAS-SEMI Clinical Practice Guide].
Ramos-Casals M, Ruiz-Irastorza G, Jiménez-Alonso J, Khamashta MA; Comité de Consenso sobre el uso de belimumab, Grupo de Trabajo de Enfermedades Autoinmunes Sistémicas (GEAS) de la Sociedad Española de Medicina Interna (SEMI). Ramos-Casals M, et al. Rev Clin Esp (Barc). 2013 Jan-Feb;213(1):42-58. doi: 10.1016/j.rce.2012.10.004. Epub 2012 Dec 22. Rev Clin Esp (Barc). 2013. PMID: 23266125 Spanish.
[Belimumab in systemic lupus erythematosus: a guide for its use in the daily practice].
Ramos-Casals M, Ruiz-Irastorza G, Jiménez-Alonso J, Khamashta MA; Grupo de Trabajo de Enfermedades Autoinmunes Sistémicas (GEAS) de la Sociedad Espa˜nola de Medicina Interna (SEMI). Ramos-Casals M, et al. Rev Clin Esp (Barc). 2013 Jan-Feb;213(1):66-7. Rev Clin Esp (Barc). 2013. PMID: 23565550 Spanish. No abstract available.
[Primary Sjögren's syndrome and lymphatic proliferation].
García-Carrasco M, Ramos-Casals M, Cervera R, Font J. García-Carrasco M, et al. Among authors: ramos casals m. Med Clin (Barc). 2000 May 20;114(19):740-6. doi: 10.1016/s0025-7753(00)71420-5. Med Clin (Barc). 2000. PMID: 10919130 Review. Spanish. No abstract available.
Emerging biological therapies in primary Sjogren's syndrome.
Ramos-Casals M, Brito-Zerón P. Ramos-Casals M, et al. Rheumatology (Oxford). 2007 Sep;46(9):1389-96. doi: 10.1093/rheumatology/kem078. Epub 2007 Jun 22. Rheumatology (Oxford). 2007. PMID: 17586555 Review.
348 results